Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals including cattle, pigs, sheep, goats, deer and other livestock. The disease can cause severe damage both direct loss in milk yield and growth in infected animals and indirect economic losses from control, treatment and trade restrictions. FMD is a endemic in parts of Asia, Africa, and South America where emergency vaccination is practiced to control outbreaks. With growing international trade and movement of livestock, controlling FMD has become more challenging, thus, requiring improved vaccination strategies and interventions.

Market Dynamics:

Global foot and mouth disease vaccine market growth is driven by factors such as increasing prevalence of FMD amongst livestock, growing outbreaks worldwide due to changes in climate and farming practices as well as international trade in animals and animal products. However, high costs associated with vaccine production and storage and reuse of equipment can hamper the market growth. Furthermore, lack of standardized regulatory guidelines for vaccine approval in different countries also hampers the market growth.  Advancements in molecular biological techniques that enables development of new generation vaccines with improved immunogenicity and cross-protection can offer market growth opportunity. Growing focus on controlling FMD in previously FMD-free countries can open new application areas.

Key Features of the Study:

• This report provides in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Biogenesis Bago, Indian Immunologicals Ltd., Boehringer Ingelheim, Vetal Animal Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation

• By Vaccine Type:
  
  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines
• By Animal Type
  
  • Cattle 
  • Sheep and Goat
  • Swine
  • Others
• By Region:              
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saúde Animal Ltda.
  • Biovet Vaxxinova
  • Veterquímica S.A.
  • MEVAC
  • Agrovet
  • Biogénesis Bagó
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnóstico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals